Autonomix shareholders approve reverse stock split authorization up to 1:50

Autonomix Medical, Inc.

Proposal to authorize reverse stock split (ratio 1:2 to 1:50) passed with 13.4M for, 3.8M against, 104.7K abstain.
All five director nominees elected: Klemp, Bisson, Foster, Robbins, Capelli each received >14.1M votes for.
Ratification of Forvis Mazars as independent auditor approved with 16.9M for, 89.6K against, 313.8K abstain.
Annual meeting held October 17, 2024; 17.35M shares voted (75.3% of outstanding).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.